MedTrace Logo

Nebulized Analgesia for Laparoscopic Appendectomy Trial

NCT02624089 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-03-22

No results posted yet for this study

Summary

The objective of this study is to assess whether the administration of nebulized intra-peritoneal ropivacaine at the onset of surgery, compared with nebulized saline, reduces morphine consumption after laparoscopic appendectomy surgery in children and adolescents.

Conditions

  • Appendicitis

Interventions

DRUG

Ropivacaine

Ropivicaine will be administered via in-line nebulization using the Aeroneb Pro™ system

DRUG

Normal saline

Normal saline will be administered via in-line nebulization using the Aeroneb Pro™ system

Sponsors & Collaborators

  • Montreal Children's Hospital of the MUHC

    collaborator OTHER

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    lead OTHER

Principal Investigators

  • Robert Baird, MDCM MSc · Assistant Professor of Pediatric Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-06-30
Completion
2017-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02624089 on ClinicalTrials.gov